1
/
of
1
Elabscience
SKU:E-EL-MK1741
Monkey F11(Coagulation Factor Ⅺ) ELISA Kit
Monkey F11(Coagulation Factor Ⅺ) ELISA Kit
Regular price
$588.00 USD
Regular price
Sale price
$588.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
The Monkey F11 (Coagulation Factor Ⅺ) ELISA Kit is a highly reliable and accurate tool designed for the quantitative detection of Coagulation Factor Ⅺ in monkey samples. This kit utilizes the enzyme-linked immunosorbent assay (ELISA) technique, which ensures high sensitivity and specificity in detecting the target protein.
The Monkey F11 ELISA Kit is composed of all the necessary components required for the assay, including pre-coated microplates, standards, controls, and reagents. The microplates are pre-coated with specific antibodies that specifically bind to Coagulation Factor Ⅺ, ensuring optimal capture of the target protein. The standards and controls provided in the kit allow for the generation of a standard curve, enabling accurate quantification of the Coagulation Factor Ⅺ concentration in the samples.
The assay procedure is simple and straightforward, with a total assay time of approximately 3 hours. The samples, standards, and controls are added to the microplate wells, followed by the addition of the detection reagent. After a brief incubation period and subsequent washing steps, a substrate solution is added, resulting in the development of a colorimetric signal. The intensity of the signal is directly proportional to the concentration of Coagulation Factor Ⅺ in the samples, which can be measured using a microplate reader at a wavelength of 450 nm.
The Monkey F11 ELISA Kit offers a wide dynamic range, allowing for the detection of Coagulation Factor Ⅺ in a variety of sample types. It is suitable for use in research laboratories, pharmaceutical companies, and clinical settings, providing valuable insights into the role of Coagulation Factor Ⅺ in various physiological and pathological processes.
With its high sensitivity, specificity, and ease of use, the Monkey F11 ELISA Kit is an indispensable tool for researchers and clinicians working in the field of coagulation research. It provides accurate and reliable results, facilitating the advancement of scientific knowledge and contributing to the development of novel therapeutic strategies targeting Coagulation Factor Ⅺ.
The Monkey F11 ELISA Kit is composed of all the necessary components required for the assay, including pre-coated microplates, standards, controls, and reagents. The microplates are pre-coated with specific antibodies that specifically bind to Coagulation Factor Ⅺ, ensuring optimal capture of the target protein. The standards and controls provided in the kit allow for the generation of a standard curve, enabling accurate quantification of the Coagulation Factor Ⅺ concentration in the samples.
The assay procedure is simple and straightforward, with a total assay time of approximately 3 hours. The samples, standards, and controls are added to the microplate wells, followed by the addition of the detection reagent. After a brief incubation period and subsequent washing steps, a substrate solution is added, resulting in the development of a colorimetric signal. The intensity of the signal is directly proportional to the concentration of Coagulation Factor Ⅺ in the samples, which can be measured using a microplate reader at a wavelength of 450 nm.
The Monkey F11 ELISA Kit offers a wide dynamic range, allowing for the detection of Coagulation Factor Ⅺ in a variety of sample types. It is suitable for use in research laboratories, pharmaceutical companies, and clinical settings, providing valuable insights into the role of Coagulation Factor Ⅺ in various physiological and pathological processes.
With its high sensitivity, specificity, and ease of use, the Monkey F11 ELISA Kit is an indispensable tool for researchers and clinicians working in the field of coagulation research. It provides accurate and reliable results, facilitating the advancement of scientific knowledge and contributing to the development of novel therapeutic strategies targeting Coagulation Factor Ⅺ.
Share
